Şalva, E. 2021. Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer . European Society Gene and Cell Therapy , (Hannover, Germany), 105.

Şalva, E., (2021). Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer . European Society Gene and Cell Therapy (pp.105). Hannover, Germany

Şalva, EMİNE. "Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer ," European Society Gene and Cell Therapy, Hannover, Germany, 2021

Şalva, EMİNE. "Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer ." European Society Gene and Cell Therapy , Hannover, Germany, pp.105, 2021

Şalva, E. (2021) . "Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer ." European Society Gene and Cell Therapy , Hannover, Germany, p.105.

@conferencepaper{conferencepaper, author={EMİNE ŞALVA}, title={Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer }, congress name={European Society Gene and Cell Therapy}, city={Hannover}, country={Germany}, year={2021}, pages={105} }